Reacted Calcium - 180 CT

Reacted Calcium - 180 CT by Ortho Molecular Products

Reacted Calcium – 180 CT is a formula designed by Ortho Molecular Products using a patented calcium chelate, which, according to the producer, is over 4 times more absorbable than traditional calcium carbonate.* This makes Reacte Calcium – 180 CT a bone health product worth considering, especially if you lack natural calcium sources in your diet.*

Who Should Consider Reacted Calcium – 180 CT?

Ortho Molecular Products Reacted Calcium may be for you if:

• you don’t consume enough calcium in your diet,*
• you were diagnosed with osteoporosis,*
• you are over 65 years old,*
• you are lactose intolerant since dairy products are the main source of this mineral,*
• you consume a lot of caffeine, sodium, alcohol, or other substances that can deplete calcium reserves in your body*

Reacted Calcium – 180 CT by Ortho Molecular Products—Effects

Reacted Calcium – 180 CT may have the following effects:

• increasing skeletal strength,*
• promoting bone density,*
• supporting healthy blood pressure*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about Reacted Calcium – 180 CT by Ortho Molecular Products

Recommendation:
Ortho Molecular Products suggest taking 1-2 Reacted Calcium capsules 3 times per day, or as directed by your healthcare professional.

Serving Size: 2 Capsules
Servings Per Container: 90

Amount Per Serving:
Vitamin D3 400 IU (as Cholecalciferol)
Calcium 500 mg (as Hydroxyapatite, DimaCal® DiCalcium Malate, TRAACS® Calcium Bisglycinate Chelate, Calcium Citrate USP)
Phosphorus 143 mg

Other Ingredients: Natural Vegetable Capsules, Microcrystalline Cellulose, Magnesium Stearate, and Silicon Dioxide.

Does Not Contain: Gluten, yeast, artificial colors and flavors.

Cautions:
If you are pregnant or nursing, consult your physician before taking this product.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Click here to view Product Info Sheet

References:

1. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press; 2010.
2. Heaney RP. Carbonate Milk Albion Chelate Citrate Hydroxyapatite. Calcif Tissue Int. 1990;46:300-4.
3. Blair HC, Robinson LJ, Huang CL, et al. Calcium and bone disease. Biofactors. 2011 May-Jun;37(3):159-67. Review. [PMID: 21674636]
4. Pelayo I, Haya J, De la Cruz JJ, et al. Raloxifene plus ossein-hydroxyapatite compound versus raloxifene plus calcium carbonate to control bone loss in postmenopausal women: a randomized trial. Menopause. 2008 Nov-Dec;15(6):1132-8. [PMID: 18791486]
5. Castelo-Branco C, Pons F, Vicente JJ, et al. Preventing postmenopausal bone loss with ossein-hydroxyapatite compounds. Results of a two-year, prospective trial. J Reprod Med. 1999 Jul;44(7):601-5. [PMID: 10442322]
6. Albertazzi P, Steel SA, Howarth EM, et al. Comparison of the effects of two different types of calcium supplementation on markers of bone metabolism in a postmenopausal osteopenic population with low calcium intake: a double-blind placebo-controlled trial. Climacteric. 2004 Mar;7(1):33-40. [PMID: 15259281]
7. Rüegsegger P, Keller A, Dambacher MA. Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females. Osteoporos Int. 1995 Jan;5(1):30-4. [PMID: 7703621]
8. Castelo-Branco C, Ciria-Recasens M, Cancelo-Hidalgo MJ, et al. Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: a meta-analysis. Menopause. 2009 Sep-Oct;16(5):984-91. [PMID: 19407667]